Molecular Imaging: Page 51

PET/CT proves clinical value in prostate cancer

By Frances Rylands-Monk

Gallium-labeled prostate-specific membrane antigen PET/CT is gaining ground in primary prostate cancer staging, delegates heard at the recent Conference on Hybrid Imaging Live, held in Barcelona, Spain.

October 30, 2018

Edinburgh team shows the way in cardiac imaging

By Rebekah Moan

To develop new techniques and better diagnose and treat heart disease, more cardiac imaging specialists are required, and cardiologists and radiologists must collaborate more closely to achieve their common goals, according to U.K. experts.

October 29, 2018

AC Immune highlights PET tracer study results

By AuntMinnieEurope.com staff writers

Swiss biopharmaceutical company AC Immune announced that its partner radiopharmaceutical firm Life Molecular Imaging presented new clinical study results for F-18 PI-2620, a novel tau PET-tracer, at the recent Clinical Trials on Alzheimer's Disease Conference in Barcelona, Spain.

October 28, 2018

Live Barcelona event shows hybrid imaging's vast potential

By Frances Rylands-Monk

PET/MRI is set to shake up tumor biology imaging and is already proving to be a useful algorithm development tool in machine learning, delegates were told at the Conference on Hybrid Imaging Live, held in Barcelona, Spain, on 26 October.

October 28, 2018

ECR 2019 abstract submissions reach record number

By AuntMinnieEurope.com staff writers

The European Society of Radiology (ESR) has received a record number of abstract submissions for the 2019 annual ECR meeting.

October 16, 2018

GE highlights new PET/CT aid at EANM 2018

By AuntMinnieEurope.com staff writers

GE Healthcare is showcasing software that enables respiratory motion management for PET/CT scans at the European Association of Nuclear Medicine (EANM 2018) annual congress held in Düsseldorf, Germany, 13-17 October.

October 14, 2018

PET/CT rivals CT for NSCLC recurrence

By Wayne Forrest

Swiss researchers have found that FDG-PET/CT is "not superior" to contrast-enhanced CT in the detection and evaluation of non-small cell lung cancer (NSCLC) recurrence two years after follow-up curative treatment. Their study was published online on 4 October in the Annals of Thoracic Surgery.

October 10, 2018

Dedicated breast PET falls short for BI-RADS 4 lesions

By Wayne Forrest

Spanish researchers testing a dedicated breast PET scanner found it had a high false-negative rate for detecting in situ carcinomas in women with BI-RADS 4 lesions. The finding raises questions about the suitability of the system for working up suspicious breast lesions, according to a 3 October study.

October 8, 2018

Don't rely on FDG-PET/CT for peripheral T-cell lymphoma outcomes

By Wayne Forrest

FDG-PET/CT won't help much in predicting progression-free or overall survival among patients with peripheral T-cell lymphoma, according to an Israeli study published in the October issue of Clinical Lymphoma, Myeloma and Leukemia.

October 7, 2018

Motion correction model could aid PET/MRI lesion detection

By Wayne Forrest

Researchers from the U.K. and Australia are reporting early success with a PET/MRI-based motion correction model that, so far, has significantly improved the detection of cancer, according to a study published in the September issue of the Journal of Nuclear Medicine.

October 1, 2018

Italians identify key PET marker for memory problems

By Wayne Forrest

Italian researchers may have discovered a reliable clinical marker that links levels of amyloid deposits in the brain with increased episodic memory impairment through florbetaben-PET imaging, according to a 22 September study in the European Journal of Nuclear Medicine and Molecular Imaging.

September 27, 2018

New device can measure PET radiotracer concentration

By Louisa Cockbill

Static PET images enable a qualitative assessment of the distribution of a radiotracer, but to improve disease prediction, a more quantitative approach is required. A retired radiation oncologist and an electrical engineer have joined forces to develop a clinically useful device.

September 26, 2018

Previous Page

Page 51 of 121

Next Page